By using nano‐curcumin in COVID‐19 patients, although it did not have a significant effect on CRP, hs‐CRP, and IL‐6, it decreased the gene expression of IL‐6 (Shojaei, Foshati, et al., 2023). Here, IL6 is linked to COVID-19.